LICENSE AGREEMENT Dated August 28, 2013 By and Between ARES TRADING S.A. And OBSEVA S.A.License Agreement • October 14th, 2016 • ObsEva SA • Pharmaceutical preparations
THIS LICENSE AGREEMENT (the “Agreement”) is dated as of August 28, 2013 (the “Effective Date”) by and between ARES TRADING SA, a Swiss corporation with registered offices at Zone Industrielle de l’Ouriettaz, 1108 Aubonne, Switzerland (“Merck Serono”) and OBSEVA S.A., a Swiss corporation with registered offices at 29, Chemin de Planta, CH-1223 Cologny (“Licensee”). Merck Serono and Licensee may be referred to herein as a “Party” or, collectively, as “Parties”.
SHAREHOLDERS AGREEMENT by and amongShareholder Agreement • October 14th, 2016 • ObsEva SA • Pharmaceutical preparations
FUND SOFINNOVA CAPITAL VII (SCVII), a French venture capital fund represented by its management company, Sofinnova Partners SAS, a company organized under the laws of France, having its registered office at Immeuble Le Centorial, 16-18 rue du 4 Septembre, 75002 Paris, France
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 14th, 2016 • ObsEva SA • Pharmaceutical preparations
